-
1
-
-
84857208654
-
7,8-dihydroxyflavone, a TrkB receptor agonist, blocks long-term spatial memory impairment caused by immobilization stress in rats
-
Andero R, Daviu N, Escorihuela RM, Nadal R, Armario A (2012). 7,8-dihydroxyflavone, a TrkB receptor agonist, blocks long-term spatial memory impairment caused by immobilization stress in rats. Hippocampus 22: 399-408.
-
(2012)
Hippocampus
, vol.22
, pp. 399-408
-
-
Andero, R.1
Daviu, N.2
Escorihuela, R.M.3
Nadal, R.4
Armario, A.5
-
2
-
-
79952728977
-
Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning
-
Andero R, Heldt SA, Ye K, Liu X, Armario A, Ressler KJ (2011). Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry 168: 163-172.
-
(2011)
Am J Psychiatry
, vol.168
, pp. 163-172
-
-
Andero, R.1
Heldt, S.A.2
Ye, K.3
Liu, X.4
Armario, A.5
Ressler, K.J.6
-
3
-
-
84877805363
-
Probing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics
-
Apawu AK, Maina FK, Taylor JR, Mathews TA (2013). Probing the ability of presynaptic tyrosine kinase receptors to regulate striatal dopamine dynamics. ACS Chem Neurosci 4: 895-904.
-
(2013)
ACS Chem Neurosci
, vol.4
, pp. 895-904
-
-
Apawu, A.K.1
Maina, F.K.2
Taylor, J.R.3
Mathews, T.A.4
-
4
-
-
49349113732
-
Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats
-
Arancibia S, Silhol M, Mouliere F, Meffre J, Hollinger I, Maurice T et al (2008). Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis 31: 316-326.
-
(2008)
Neurobiol Dis
, vol.31
, pp. 316-326
-
-
Arancibia, S.1
Silhol, M.2
Mouliere, F.3
Meffre, J.4
Hollinger, I.5
Maurice, T.6
-
5
-
-
0036851840
-
Food intake, water intake, and drinking spout side preference of 28 mouse strains
-
Bachmanov AA, Reed DR, Beauchamp GK, Tordoff MG (2002). Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav Genet 32: 435-443.
-
(2002)
Behav Genet
, vol.32
, pp. 435-443
-
-
Bachmanov, A.A.1
Reed, D.R.2
Beauchamp, G.K.3
Tordoff, M.G.4
-
6
-
-
21344433902
-
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
-
Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV et al (2005). Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler Other Motor Neuron Disord 6: 100-103.
-
(2005)
Amyotroph Lateral Scler Other Motor Neuron Disord
, vol.6
, pp. 100-103
-
-
Beck, M.1
Flachenecker, P.2
Magnus, T.3
Giess, R.4
Reiners, K.5
Toyka, K.V.6
-
7
-
-
40649120726
-
BDNF is essential to promote persistence of long-term memory storage
-
Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A et al (2008). BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci USA 105: 2711-2716.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 2711-2716
-
-
Bekinschtein, P.1
Cammarota, M.2
Katche, C.3
Slipczuk, L.4
Rossato, J.I.5
Goldin, A.6
-
8
-
-
14444285507
-
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein e genotype
-
Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC et al (1998). Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55: 326-335.
-
(1998)
Arch Neurol
, vol.55
, pp. 326-335
-
-
Berg, L.1
McKeel Jr., D.W.2
Miller, J.P.3
Storandt, M.4
Rubin, E.H.5
Morris, J.C.6
-
9
-
-
84877771398
-
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
-
Chalermpalanupap T, Kinkead B, Hu WT, Kummer MP, Hammerschmidt T, Heneka MT et al (2013). Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease. Alzheimers Res Ther 5: 21.
-
(2013)
Alzheimers Res Ther
, vol.5
, pp. 21
-
-
Chalermpalanupap, T.1
Kinkead, B.2
Hu, W.T.3
Kummer, M.P.4
Hammerschmidt, T.5
Heneka, M.T.6
-
10
-
-
79958051229
-
Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex
-
Chan CB, Liu X, Pradoldej S, Hao C, An J, Yepes M et al (2011). Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex. J Neurosci 31: 8083-8092.
-
(2011)
J Neurosci
, vol.31
, pp. 8083-8092
-
-
Chan, C.B.1
Liu, X.2
Pradoldej, S.3
Hao, C.4
An, J.5
Yepes, M.6
-
11
-
-
0033360356
-
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
-
Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M et al (1999). Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2: 271-276.
-
(1999)
Nat Neurosci
, vol.2
, pp. 271-276
-
-
Chapman, P.F.1
White, G.L.2
Jones, M.W.3
Cooper-Blacketer, D.4
Marshall, V.J.5
Irizarry, M.6
-
12
-
-
77249140499
-
Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear
-
Choi DC, Maguschak KA, Ye K, Jang SW, Myers KM, Ressler KJ (2010). Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci USA 107: 2675-2680.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 2675-2680
-
-
Choi, D.C.1
Maguschak, K.A.2
Ye, K.3
Jang, S.W.4
Myers, K.M.5
Ressler, K.J.6
-
13
-
-
5344272541
-
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
-
Coleman P, Federoff H, Kurlan R (2004). A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63: 1155-1162.
-
(2004)
Neurology
, vol.63
, pp. 1155-1162
-
-
Coleman, P.1
Federoff, H.2
Kurlan, R.3
-
14
-
-
84856059838
-
7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease
-
Devi L, Ohno M (2012). 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 37: 434-444.
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 434-444
-
-
Devi, L.1
Ohno, M.2
-
15
-
-
84855904096
-
Brain-derived neurotrophic factor and Alzheimer's disease: Physiopathology and beyond
-
Diniz BS, Teixeira AL (2011). Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med 13: 217-222.
-
(2011)
Neuromolecular Med
, vol.13
, pp. 217-222
-
-
Diniz, B.S.1
Teixeira, A.L.2
-
16
-
-
33750950147
-
The dynamic distribution of TrkB receptors before, during, and after synapse formation between cortical neurons
-
Gomes RA, Hampton C, El-Sabeawy F, Sabo SL, McAllister AK (2006). The dynamic distribution of TrkB receptors before, during, and after synapse formation between cortical neurons. J Neurosci 26: 11487-11500.
-
(2006)
J Neurosci
, vol.26
, pp. 11487-11500
-
-
Gomes, R.A.1
Hampton, C.2
El-Sabeawy, F.3
Sabo, S.L.4
McAllister, A.K.5
-
17
-
-
84871948613
-
Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress
-
Gupta VK, You Y, Li JC, Klistorner A, Graham SL (2013). Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress. J Mol Neurosci 49: 96-104.
-
(2013)
J Mol Neurosci
, vol.49
, pp. 96-104
-
-
Gupta, V.K.1
You, Y.2
Li, J.C.3
Klistorner, A.4
Graham, S.L.5
-
18
-
-
84873087532
-
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
-
Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A et al (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493: 674-678.
-
(2013)
Nature
, vol.493
, pp. 674-678
-
-
Heneka, M.T.1
Kummer, M.P.2
Stutz, A.3
Delekate, A.4
Schwartz, S.5
Vieira-Saecker, A.6
-
19
-
-
84878152890
-
Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation
-
Hiester BG, Galati DF, Salinas PC, Jones KR (2013). Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation. Mol Cell Neurosci 56C: 115-127.
-
(2013)
Mol Cell Neurosci
, vol.56 C
, pp. 115-127
-
-
Hiester, B.G.1
Galati, D.F.2
Salinas, P.C.3
Jones, K.R.4
-
20
-
-
84870228676
-
SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease
-
Hong Y, Chan CB, Kwon IS, Li X, Song M, Lee HP et al (2012). SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease. J Neurosci 32: 17262-17272.
-
(2012)
J Neurosci
, vol.32
, pp. 17262-17272
-
-
Hong, Y.1
Chan, C.B.2
Kwon, I.S.3
Li, X.4
Song, M.5
Lee, H.P.6
-
21
-
-
78651483724
-
PKC epsilon activation prevents synaptic loss, Abeta elevation, and cognitive deficits in Alzheimer's disease transgenic mice
-
Hongpaisan J, Sun MK, Alkon DL (2011). PKC epsilon activation prevents synaptic loss, Abeta elevation, and cognitive deficits in Alzheimer's disease transgenic mice. J Neurosci 31: 630-643.
-
(2011)
J Neurosci
, vol.31
, pp. 630-643
-
-
Hongpaisan, J.1
Sun, M.K.2
Alkon, D.L.3
-
22
-
-
77249168715
-
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
-
Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y et al (2010). A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci USA 107: 2687-2692.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 2687-2692
-
-
Jang, S.W.1
Liu, X.2
Yepes, M.3
Shepherd, K.R.4
Miller, G.W.5
Liu, Y.6
-
23
-
-
40449135167
-
Beta-amyloid burden is not associated with rates of brain atrophy
-
Josephs KA, Whitwell JL, Ahmed Z, Shiung MM, Weigand SD, Knopman DS et al (2008). Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63: 204-212.
-
(2008)
Ann Neurol
, vol.63
, pp. 204-212
-
-
Josephs, K.A.1
Whitwell, J.L.2
Ahmed, Z.3
Shiung, M.M.4
Weigand, S.D.5
Knopman, D.S.6
-
24
-
-
58149479368
-
Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model
-
Kimura R, Ohno M (2009). Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 33: 229-235.
-
(2009)
Neurobiol Dis
, vol.33
, pp. 229-235
-
-
Kimura, R.1
Ohno, M.2
-
25
-
-
78649857797
-
A Synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect
-
Liu X, Chan CB, Jang SW, Pradoldej S, Huang J, He K et al (2010). A Synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J Med Chem 53: 8274-8286.
-
(2010)
J Med Chem
, vol.53
, pp. 8274-8286
-
-
Liu, X.1
Chan, C.B.2
Jang, S.W.3
Pradoldej, S.4
Huang, J.5
He, K.6
-
26
-
-
84874263260
-
O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity
-
Liu X, Qi Q, Xiao G, Li J, Luo HR, Ye K (2013). O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity. Pharmacology 91: 185-200.
-
(2013)
Pharmacology
, vol.91
, pp. 185-200
-
-
Liu, X.1
Qi, Q.2
Xiao, G.3
Li, J.4
Luo, H.R.5
Ye, K.6
-
27
-
-
84878227058
-
BDNFbased synaptic repair as a disease-modifying strategy for neurodegenerative diseases
-
Lu B, Nagappan G, Guan X, Nathan PJ, Wren P (2013). BDNFbased synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci 14: 401-416.
-
(2013)
Nat Rev Neurosci
, vol.14
, pp. 401-416
-
-
Lu, B.1
Nagappan, G.2
Guan, X.3
Nathan, P.J.4
Wren, P.5
-
28
-
-
84855836040
-
The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission
-
Mantilla CB, Ermilov LG (2012). The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission. Muscle Nerve 45: 274-276.
-
(2012)
Muscle Nerve
, vol.45
, pp. 274-276
-
-
Mantilla, C.B.1
Ermilov, L.G.2
-
29
-
-
0036501401
-
Noradrenergic changes, aggressive behavior, and cognition in patients with dementia
-
Matthews KL, Chen CP, Esiri MM, Keene J, Minger SL, Francis PT (2002). Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry 51: 407-416.
-
(2002)
Biol Psychiatry
, vol.51
, pp. 407-416
-
-
Matthews, K.L.1
Chen, C.P.2
Esiri, M.M.3
Keene, J.4
Minger, S.L.5
Francis, P.T.6
-
30
-
-
0032890036
-
An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease
-
Murer MG, Boissiere F, Yan Q, Hunot S, Villares J, Faucheux B et al (1999). An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 88: 1015-1032.
-
(1999)
Neuroscience
, vol.88
, pp. 1015-1032
-
-
Murer, M.G.1
Boissiere, F.2
Yan, Q.3
Hunot, S.4
Villares, J.5
Faucheux, B.6
-
31
-
-
0035239020
-
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease
-
Murer MG, Yan Q, Raisman-Vozari R (2001). Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63: 71-124.
-
(2001)
Prog Neurobiol
, vol.63
, pp. 71-124
-
-
Murer, M.G.1
Yan, Q.2
Raisman-Vozari, R.3
-
32
-
-
62049083420
-
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
-
Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM et al (2009). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15: 331-337.
-
(2009)
Nat Med
, vol.15
, pp. 331-337
-
-
Nagahara, A.H.1
Merrill, D.A.2
Coppola, G.3
Tsukada, S.4
Schroeder, B.E.5
Shaked, G.M.6
-
33
-
-
0030451939
-
Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease
-
Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H (1996). Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 7: 2925-2928.
-
(1996)
Neuroreport
, vol.7
, pp. 2925-2928
-
-
Narisawa-Saito, M.1
Wakabayashi, K.2
Tsuji, S.3
Takahashi, H.4
Nawa, H.5
-
34
-
-
33749521100
-
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation
-
Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J et al (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26: 10129-10140.
-
(2006)
J Neurosci
, vol.26
, pp. 10129-10140
-
-
Oakley, H.1
Cole, S.L.2
Logan, S.3
Maus, E.4
Shao, P.5
Craft, J.6
-
35
-
-
0034208461
-
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis
-
Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J et al (2000). A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 201-206.
-
(2000)
Amyotroph Lateral Scler Other Motor Neuron Disord
, vol.1
, pp. 201-206
-
-
Ochs, G.1
Penn, R.D.2
York, M.3
Giess, R.4
Beck, M.5
Tonn, J.6
-
36
-
-
0042697305
-
Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction
-
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R et al (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
-
(2003)
Neuron
, vol.39
, pp. 409-421
-
-
Oddo, S.1
Caccamo, A.2
Shepherd, J.D.3
Murphy, M.P.4
Golde, T.E.5
Kayed, R.6
-
37
-
-
0025993361
-
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
-
Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991). BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7: 695-702.
-
(1991)
Neuron
, vol.7
, pp. 695-702
-
-
Phillips, H.S.1
Hains, J.M.2
Armanini, M.3
Laramee, G.R.4
Johnson, S.A.5
Winslow, J.W.6
-
38
-
-
84881396465
-
Site-specific inhibitory mechanism for amyloidbeta42 aggregation by catechol-type flavonoids targeting the Lys residues
-
Sato M, Murakami K, Uno M, Nakagawa Y, Katayama S, Akagi KI et al (2013). Site-specific inhibitory mechanism for amyloidbeta42 aggregation by catechol-type flavonoids targeting the Lys residues. J Biol Chem 188: 23212-23224.
-
(2013)
J Biol Chem
, vol.188
, pp. 23212-23224
-
-
Sato, M.1
Murakami, K.2
Uno, M.3
Nakagawa, Y.4
Katayama, S.5
Akagi, K.I.6
-
39
-
-
79957872121
-
Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease
-
Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ (2011). Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 24: 547-557.
-
(2011)
J Alzheimers Dis
, vol.24
, pp. 547-557
-
-
Scheff, S.W.1
Price, D.A.2
Schmitt, F.A.3
Scheff, M.A.4
Mufson, E.J.5
-
40
-
-
0037174618
-
Alzheimer's disease is a synaptic failure
-
Selkoe DJ (2002). Alzheimer's disease is a synaptic failure. Science 298: 789-791.
-
(2002)
Science
, vol.298
, pp. 789-791
-
-
Selkoe, D.J.1
-
41
-
-
0030872413
-
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease
-
Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ (1997). Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 56: 933-944.
-
(1997)
J Neuropathol Exp Neurol
, vol.56
, pp. 933-944
-
-
Sze, C.I.1
Troncoso, J.C.2
Kawas, C.3
Mouton, P.4
Price, D.L.5
Martin, L.J.6
-
42
-
-
0025987048
-
Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
-
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580.
-
(1991)
Ann Neurol
, vol.30
, pp. 572-580
-
-
Terry, R.D.1
Masliah, E.2
Salmon, D.P.3
Butters, N.4
Deteresa, R.5
Hill, R.6
-
43
-
-
45249087489
-
Functional consequences of locus coeruleus degeneration in Alzheimer's disease
-
Weinshenker D (2008). Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr Alzheimer Res 5: 342-345.
-
(2008)
Curr Alzheimer Res
, vol.5
, pp. 342-345
-
-
Weinshenker, D.1
-
44
-
-
84864124228
-
7,8-dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats
-
Zeng Y, Lv F, Li L, Yu H, Dong M, Fu Q (2012). 7,8-dihydroxyflavone rescues spatial memory and synaptic plasticity in cognitively impaired aged rats. J Neurochem 122: 800-811.
-
(2012)
J Neurochem
, vol.122
, pp. 800-811
-
-
Zeng, Y.1
Lv, F.2
Li, L.3
Yu, H.4
Dong, M.5
Fu, Q.6
-
45
-
-
83055185674
-
Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging
-
Zeng Y, Tan M, Kohyama J, Sneddon M, Watson JB, Sun YE et al (2011). Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging. J Neurosci 31: 17800-17810.
-
(2011)
J Neurosci
, vol.31
, pp. 17800-17810
-
-
Zeng, Y.1
Tan, M.2
Kohyama, J.3
Sneddon, M.4
Watson, J.B.5
Sun, Y.E.6
-
46
-
-
72949089907
-
Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: Implications for neuritic plaque development
-
Zhang XM, Cai Y, Xiong K, Cai H, Luo XG, Feng JC et al (2009). Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 30: 2271-2283.
-
(2009)
Eur J Neurosci
, vol.30
, pp. 2271-2283
-
-
Zhang, X.M.1
Cai, Y.2
Xiong, K.3
Cai, H.4
Luo, X.G.5
Feng, J.C.6
-
47
-
-
68849083063
-
Brain-derived neurotrophic factor in neurodegenerative diseases
-
Zuccato C, Cattaneo E (2009). Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5: 311-322.
-
(2009)
Nat Rev Neurol
, vol.5
, pp. 311-322
-
-
Zuccato, C.1
Cattaneo, E.2
|